Envoy Medical Statistics
Share Statistics
Envoy Medical has 20.24M shares outstanding. The number of shares has increased by 354.46% in one year.
| Shares Outstanding | 20.24M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 8.06M |
| Failed to Deliver (FTD) Shares | 956 |
| FTD / Avg. Volume | 0.4% |
Short Selling Information
The latest short interest is 46.88K, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 46.88K |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.7% |
| Short Ratio (days to cover) | 1.75 |
Valuation Ratios
The PE ratio is -0.76 and the forward PE ratio is -1.88.
| PE Ratio | -0.76 |
| Forward PE | -1.88 |
| PS Ratio | 71.93 |
| Forward PS | 120.9 |
| PB Ratio | -12.9 |
| P/FCF Ratio | -1.28 |
| PEG Ratio | n/a |
Enterprise Valuation
Envoy Medical Inc. has an Enterprise Value (EV) of 19.07M.
| EV / Earnings | -0.64 |
| EV / Sales | 60.36 |
| EV / EBITDA | -1.05 |
| EV / EBIT | -1.04 |
| EV / FCF | -1.07 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.
| Current Ratio | 1.03 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 16.97% and return on capital (ROIC) is 1530.92%.
| Return on Equity (ROE) | 16.97% |
| Return on Assets (ROA) | -3.91% |
| Return on Capital (ROIC) | 1530.92% |
| Revenue Per Employee | 9.29K |
| Profits Per Employee | -879.65K |
| Employee Count | 34 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.56 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -18.78% in the last 52 weeks. The beta is 2.36, so Envoy Medical 's price volatility has been higher than the market average.
| Beta | 2.36 |
| 52-Week Price Change | -18.78% |
| 50-Day Moving Average | 2.39 |
| 200-Day Moving Average | 3.27 |
| Relative Strength Index (RSI) | 42.07 |
| Average Volume (20 Days) | 241.44K |
Income Statement
In the last 12 months, Envoy Medical had revenue of $316.00K and earned -$29.91M in profits. Earnings per share was $-2.38.
| Revenue | 316.00K |
| Gross Profit | -473.00K |
| Operating Income | -18.37M |
| Net Income | -29.91M |
| EBITDA | -18.24M |
| EBIT | -18.37M |
| Earnings Per Share (EPS) | -2.38 |
Balance Sheet
The company has $4.22M in cash and $562.00K in debt, giving a net cash position of $3.66M.
| Cash & Cash Equivalents | 4.22M |
| Total Debt | 562.00K |
| Net Cash | 3.66M |
| Retained Earnings | -257.24M |
| Total Assets | 9.40M |
| Working Capital | -1.94M |
Cash Flow
In the last 12 months, operating cash flow was -$17.65M and capital expenditures -$153.00K, giving a free cash flow of -$17.81M.
| Operating Cash Flow | -17.65M |
| Capital Expenditures | -153.00K |
| Free Cash Flow | -17.81M |
| FCF Per Share | -1.42 |
Margins
Gross margin is -149.68%, with operating and profit margins of -5.81K% and -9.46K%.
| Gross Margin | -149.68% |
| Operating Margin | -5.81K% |
| Pretax Margin | -9.46K% |
| Profit Margin | -9.46K% |
| EBITDA Margin | -5.77K% |
| EBIT Margin | -5.81K% |
| FCF Margin | -5.64K% |
Dividends & Yields
COCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -119.6% |
| FCF Yield | -44.17% |
Analyst Forecast
The average price target for COCH is $9, which is 352.3% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9 |
| Price Target Difference | 352.3% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -48.55 |
| Piotroski F-Score | 1 |